Log In: Home News Newsletter About Us Mission and Vision Constitution and Bylaws Become a Member What is Neuropsychiatry? Glossary What is Neuropsychology Officers 2013 Awards 2012 Awards 2011 Awards 2010 Awards Council Members Committees and Task Forces Awards Committee Bylaws Committee Finance and Development Committee Committee on Research Education Committee Membership Committee Public Policy and Communication Scientific Program Committee ANPA Fellowship Application Fellows Subspecialty Certification ANPA Oral History Tucker Award Meetings 2014 Annual Meeting Previous Meeting Programs Related Meetings of Interest TRAINING UCNS Fellowships Neuropsychiatry Training Objectives for General Psychiatry Residents Resources Member Directory Research Database Committee on Research Published Reports Journal of Neuropsychiatry and Clinical Neurosciences United Council for Neurologic Subspecialties Employment Opportunities Members Only Modify your profile Pay Dues View transactions and print receipts View Bylaws Officer and Council Member Contacts Member Directory Committee Chairs and Task Force Chairs Contacts Special Interest Groups Contact Us Search
Member Directory Research Database Committee on Research Published Reports Journal of Neuropsychiatry and Clinical Neurosciences United Council for Neurologic Subspecialties Employment Opportunities	Title Serotonin PET Imaging in Frontotemporal Dementia Investigator Tiffany Chow, MD Other Investigators Sandra Black, MD; Morris Freedman, MD; Paul Verhoeff, MD; Jeffrey Meyer, MD Contact Email tchow@rotman-baycrest.on.ca Brief Abstract Our overall hypothesis is that serotonin 1a receptor (5HT1aR) loss is directly associated with a subset of the mood and behaviour changes observed in FTD. This study utilizes positron emission tomography (PET) neuroimaging with a radioligand for 5HT1aR. With this technology, we can take in vivo measures of 5HT1aR early in the course of illness, while the patient experiences the target neuropsychiatric symptoms. This implies the ability to associate the level of 5HT1aR loss with the severity of clinical disturbance due to FTD. Inclusion/Exclusion Criteria Neary criteria for FTD. Must be able to tolerate MRI scan. Opportunities for Collaboration Data on 5HT1aR may be useful for correlation with behavioral findings, response to pharmacotherapy.
American Neuropsychiatric Association • 700 Ackerman Road, Suite 625  • Columbus, OH 43202 • 614.447.2077